2024-10-22 19:30:32
Akeso Announces IND Approval from China NMPA for Phase II Clinical Trial of Cadonilimab in Combination with Docetaxel to Treat NSCLC
Corporate/ 2023-07-24
Akeso Announces IND Approval from China ...

HONG KONG,March 8,2022-- Akeso,Inc. (9926.HK) ("Akeso"),a biopharmaceutical company dedicated to the development of innovative ant...

Nippon Express USA Acquires GDP Certification for CFS in Los Angeles and New York
Health/ 2023-07-22
Nippon Express USA Acquires GDP Certific...

TOKYO,March 8,2022-- Nippon Express USA,Inc. (hereinafter "NX USA"),a group company of Nippon Express Holdings,Inc.,has obtained G...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release